🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

One question for the future public inquiry into the government response to the pandemic—how was it that the medical and scientific establishment was co-opted into supporting the government line? COVID-19 will be a case study in the death of independent scientific advice.

CNN, NBC, CBS, & ABC are set to announce that they will no longer televise Trumps announcements from the White House, saying that they are not in the public interest. They are standing firm, claiming that they are actually protecting the American public.

55,000 dead (FT estimate), 20,000 new cases every day after seven weeks of lockdown, and a vertical and outsourced test, trace, isolate fiasco, the disastrous March 12 herd immunity strategy has led to public health and economic chaos.

(1/2) We are deeply concerned that recent actions from Government appear to undermine essential public health messaging at this crucial time. It is vital that all in society continue to follow guidance to prevent the spread of COVID-19 and save lives...

(2/2) If there is doubt regarding the actions of those involved with Government, FPH supports at the very least, an inquiry into the matter.

Boris Johnson insists we must “move on” from questions about Dominic Cummings, but the public isn’t ready for moving on. The public is furious. This government is supporting the instincts of one individual over the collective interests of the nation. This is unacceptable.

In our latest paper with Aris Angelis - Άρης Αγγελής and Larry Phillips and in response to the Institute for Clinical and Economic Review’s (ICER) recent update to its value assessment framework, we are commenting on the method by which the bene…lnkd.in/gPxgPi4 lnkd.in/gfY3WyG

Excellent presentation by professor @kanavosPG regarding one of the more complex issues which Chile is facing.

Pax Mediterranea !

Another Saturday, listening and learning Health Technology Assessment from Panos Kanavos interpreting clinical trial results assessments #pharmacoeconomy LSE Health Policy #healtheconomics 💊 💵

Panos Kanavos Panos Kanavos LSE Health Policy: The benefit of primary prevention manifests itself in the future, this is a challenge for funding. We need to find alternative ways to fund healthcare #QuestionsInspireSolutions #WeWontRest bit.ly/37KW7rw

A critical discussion by multi-stakeholder panelists about #CVD on #EU #Europe level. Political leadership, partnerships, synergies, keeping health high on political agenda, coordinated, targeted care delivery, disease specific vs #NCD #PatientsVoice #QuestionsInspireSolutions

Now at #EHFG2021 Claudio Jommi SDA Bocconi and Panos Kanavos discussing the pros and cons as well as trajectories of reforms for #innovative medicines funding. Glad to see the discussions about the challenges of financing #cancer care are drawing much attention!

Despite substantial progress in #cancer care during the last decade, researchers & policy experts agreed that challenges persist when it comes to improving access to care & halting the burden of cancer. But there are also opportunities! Thanks for a great discussion at #EHFG2021

"Rethinking Our Pricing Perspective" is in process with "The Price Components Impact on Drugs Affordability" being the topic of discussion at the Novartis sponsored symposium. #ISPORLA

iMPACT HTA is very proud to share the DICE platform based on Discretely Integrated Condition Event simulation to model health benefits and treatment costs during CEA modelling. Access:impact-hta.eu/work-package-2